1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Craik, D.J.
Norman, D.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
34
4147
4158
10.1021/bi00013a002
7703226
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1.
1995
NO
Medd.Nor.Farm.Selsk.
MNFSAW
2057
0029-1927
32
173
An Oxytocic Principle Found in Oldenlandia Affinis Dc
1970
10.2210/pdb1kal/pdb
pdb_00001kal
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2917.344
KALATA B1
1
man
polymer
no
no
SWPVCTRNGLPVCGETCVGGTCNTPGCTC
SWPVCTRNGLPVCGETCVGGTCNTPGCTC
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Oldenlandia
sample
60225
Oldenlandia affinis
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-03-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1995-01-13
REL
REL
10
BRUNGER
refinement
X-PLOR
SER
1
n
1
SER
1
A
TRP
2
n
2
TRP
2
A
PRO
3
n
3
PRO
3
A
VAL
4
n
4
VAL
4
A
CYS
5
n
5
CYS
5
A
THR
6
n
6
THR
6
A
ARG
7
n
7
ARG
7
A
ASN
8
n
8
ASN
8
A
GLY
9
n
9
GLY
9
A
LEU
10
n
10
LEU
10
A
PRO
11
n
11
PRO
11
A
VAL
12
n
12
VAL
12
A
CYS
13
n
13
CYS
13
A
GLY
14
n
14
GLY
14
A
GLU
15
n
15
GLU
15
A
THR
16
n
16
THR
16
A
CYS
17
n
17
CYS
17
A
VAL
18
n
18
VAL
18
A
GLY
19
n
19
GLY
19
A
GLY
20
n
20
GLY
20
A
THR
21
n
21
THR
21
A
CYS
22
n
22
CYS
22
A
ASN
23
n
23
ASN
23
A
THR
24
n
24
THR
24
A
PRO
25
n
25
PRO
25
A
GLY
26
n
26
GLY
26
A
CYS
27
n
27
CYS
27
A
THR
28
n
28
THR
28
A
CYS
29
n
29
CYS
29
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ARG
7
A
N
ARG
7
A
O
LEU
10
A
O
LEU
10
1
A
A
N
C
SER
CYS
1
29
1.30
2
A
A
N
C
SER
CYS
1
29
1.30
3
A
A
N
C
SER
CYS
1
29
1.30
4
A
A
N
C
SER
CYS
1
29
1.31
5
A
A
N
C
SER
CYS
1
29
1.30
6
A
A
N
C
SER
CYS
1
29
1.30
7
A
A
N
C
SER
CYS
1
29
1.30
8
A
A
N
C
SER
CYS
1
29
1.30
9
A
A
N
C
SER
CYS
1
29
1.30
10
A
A
N
C
SER
CYS
1
29
1.30
1
A
ARG
7
0.309
SIDE CHAIN
2
A
ARG
7
0.309
SIDE CHAIN
3
A
ARG
7
0.182
SIDE CHAIN
4
A
ARG
7
0.315
SIDE CHAIN
5
A
ARG
7
0.289
SIDE CHAIN
6
A
ARG
7
0.311
SIDE CHAIN
8
A
ARG
7
0.301
SIDE CHAIN
9
A
ARG
7
0.279
SIDE CHAIN
10
A
ARG
7
0.283
SIDE CHAIN
1
-22.69
2.70
111.00
88.31
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
1
-6.78
1.00
110.10
103.32
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
1
7.59
0.90
109.00
116.59
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
1
8.26
1.10
130.40
138.66
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
2
-23.98
2.70
111.00
87.02
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
2
-6.82
1.00
110.10
103.28
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
2
7.55
0.90
109.00
116.55
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
2
7.85
1.10
130.40
138.25
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
3
-23.20
2.70
111.00
87.80
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
3
-6.86
1.00
110.10
103.24
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
3
7.60
0.90
109.00
116.60
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
3
7.94
1.10
130.40
138.34
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
4
-21.39
2.70
111.00
89.61
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
4
-6.77
1.00
110.10
103.33
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
4
7.41
0.90
109.00
116.41
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
4
7.53
1.10
130.40
137.93
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
5
-23.76
2.70
111.00
87.24
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
5
-7.22
1.00
110.10
102.88
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
5
7.53
0.90
109.00
116.53
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
5
7.43
1.10
130.40
137.83
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
6
-23.38
2.70
111.00
87.62
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
6
-7.17
1.00
110.10
102.93
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
6
7.71
0.90
109.00
116.71
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
6
7.49
1.10
130.40
137.89
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
7
-23.57
2.70
111.00
87.43
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
7
-6.82
1.00
110.10
103.28
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
7
7.55
0.90
109.00
116.55
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
7
8.52
1.10
130.40
138.92
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
7
7.24
1.10
114.20
121.44
A
A
A
CA
CB
SG
CYS
CYS
CYS
5
5
5
N
8
-23.46
2.70
111.00
87.54
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
8
-7.21
1.00
110.10
102.89
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
8
7.74
0.90
109.00
116.74
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
8
7.76
1.10
130.40
138.16
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
8
10.56
1.10
114.20
124.76
A
A
A
CA
CB
SG
CYS
CYS
CYS
5
5
5
N
9
-22.32
2.70
111.00
88.68
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
9
-6.87
1.00
110.10
103.23
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
9
7.60
0.90
109.00
116.60
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
9
7.78
1.10
130.40
138.18
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
10
-22.31
2.70
111.00
88.69
A
A
A
N
CA
C
SER
SER
SER
1
1
1
N
10
-6.86
1.00
110.10
103.24
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
2
2
2
N
10
7.51
0.90
109.00
116.51
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
2
2
2
N
10
8.01
1.10
130.40
138.41
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
2
2
2
N
10
7.48
1.10
114.20
121.68
A
A
A
CA
CB
SG
CYS
CYS
CYS
17
17
17
N
1
A
TRP
2
-0.46
-70.19
1
A
PRO
11
-48.72
100.98
1
A
CYS
17
-140.78
42.11
1
A
PRO
25
-38.36
111.18
2
A
TRP
2
1.45
-71.86
2
A
PRO
11
-50.73
81.56
2
A
VAL
12
-150.44
42.05
2
A
CYS
17
-140.88
40.46
2
A
CYS
22
-121.19
-50.38
3
A
TRP
2
2.11
-71.77
3
A
PRO
11
-50.00
83.42
3
A
VAL
12
-147.11
48.40
4
A
TRP
2
-5.74
-65.48
4
A
PRO
11
-51.24
85.71
4
A
VAL
12
-151.03
31.32
4
A
CYS
17
-147.53
43.18
4
A
THR
21
-120.13
-73.44
4
A
CYS
22
59.44
-73.92
5
A
TRP
2
-0.98
-67.87
5
A
PRO
11
-52.61
83.51
5
A
VAL
12
-163.47
41.36
5
A
CYS
17
-142.26
40.76
5
A
THR
21
-106.50
-60.78
5
A
CYS
22
-4.60
-73.95
5
A
ASN
23
21.04
57.61
5
A
PRO
25
-57.10
102.65
6
A
TRP
2
-2.46
-67.31
6
A
PRO
11
-51.49
83.80
6
A
VAL
12
-146.53
39.37
6
A
CYS
17
-142.59
39.42
6
A
THR
21
-124.92
-141.28
6
A
CYS
22
115.70
-70.11
6
A
ASN
23
30.62
52.46
7
A
TRP
2
2.86
-72.64
7
A
PRO
11
-52.65
93.50
7
A
VAL
12
-141.42
36.84
7
A
CYS
17
-143.39
41.54
7
A
THR
21
-130.19
-141.29
7
A
CYS
22
122.75
-64.10
7
A
ASN
23
37.59
57.50
7
A
PRO
25
-58.96
91.57
8
A
TRP
2
0.59
-69.05
8
A
CYS
17
-141.98
40.10
8
A
THR
21
-105.58
-84.63
8
A
CYS
22
-6.34
99.00
9
A
TRP
2
-4.03
-65.89
9
A
ASN
8
36.39
46.86
9
A
PRO
11
-60.18
91.64
9
A
CYS
17
-146.05
42.75
9
A
THR
21
-127.34
-99.74
9
A
CYS
22
90.83
-59.75
10
A
TRP
2
0.28
-69.61
10
A
VAL
12
146.20
50.50
10
A
THR
21
169.34
159.55
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
ELUCIDATION OF THE PRIMARY AND THREE-DIMENSIONAL STRUCTURE OF THE UTEROTONIC POLYPEPTIDE KALATA B1
1
Y
N
disulf
2.021
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
22
A
SG
CYS
22
1_555
disulf
2.017
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
27
A
SG
CYS
27
1_555
disulf
2.020
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
29
A
SG
CYS
29
1_555
PLANT PROTEIN
PLANT PROTEIN
KAB1_OLDAF
UNP
1
1
P56254
TCVGGTCNTPGCTCSWPVCTRNGLPVCGE
15
29
1KAL
1
15
P56254
A
1
1
15
2
anti-parallel
A
THR
6
A
THR
6
A
ARG
7
A
ARG
7
A
LEU
10
A
LEU
10
A
PRO
11
A
PRO
11
1
P 1